SCHEMBL39259

SCHEMBL39259

CCOC(=O)c1cc(O)ccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 9/20 1.00
CA1 P00915 9/20 1.00
CA2 P00918 9/20 1.00
CA7 P43166 9/20 1.00
CA9 Q16790 9/20 1.00
CA14 Q9ULX7 9/20 1.00
EGFR P00533 2/20 0.65
ESR1 P03372 1/20 0.56
ESR2 Q92731 1/20 0.56
KMT2A Q03164 1/20 0.56
TSHR P16473 1/20 0.55
NR1H2 P55055 1/20 0.55
NR1H3 Q13133 1/20 0.55
MIF P14174 1/20 0.54
PFKFB3 Q16875 1/20 0.54
MAOA P21397 1/20 0.54
MAOB P27338 1/20 0.54
SERPINE1 P05121 1/20 0.53
ALOX5 P09917 1/20 0.52
PTGS2 P35354 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29457603 1.00 CA12 (1.00) CA12CA1CA2CA7CA9
SCHEMBL10449048 0.87 CA12 (0.77) CA12CA1CA2CA7CA9
SCHEMBL3454263 0.86 CA12 (0.75) CA12CA1CA2CA7CA9
SCHEMBL30968706 0.85 CA12 (1.00) CA12CA1CA2CA7CA9
SCHEMBL30968705 0.85 CA12 (1.00) CA12CA1CA2CA7CA9
SCHEMBL1641611 0.85 CA12 (0.74) CA12CA1CA2CA7CA9
SCHEMBL2543216 0.85 CA12 (1.00) CA12CA1CA2CA7CA9
SCHEMBL550228 0.85 CA12 (0.74) CA12CA1CA2CA7CA9
SCHEMBL18372775 0.85 CA12 (0.73) CA12CA1CA2CA7CA9
SCHEMBL13286843 0.85 CA12 (0.73) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11673997-B2 Work time to walk-on time ratio by adding a phenolic catalyst to polyaspartic flooring formulations COVESTRO LLC (US) 2023-06-13 US claimed
CN-113999386-B Polyaryletherketone resin containing carboxyl side group and synthesis method thereof 浙江鹏孚隆新材料有限公司 2023-06-06 CN claimed
CN-114805811-A Polyarylether resin containing carboxyl side group, synthesis method and application of polyarylether resin in coating 浙江鹏孚隆新材料有限公司 2022-07-29 CN claimed
CN-114144454-A Improved operating time to open-run time ratio by adding phenolic catalysts to polyaspartic flooring formulations 科思创有限公司 2022-03-04 CN claimed
CN-113999386-A Polyaryletherketone resin containing carboxyl side group and synthesis method thereof 浙江鹏孚隆新材料有限公司 2022-02-01 CN claimed
US-20210032407-A1 WORK TIME TO WALK-ON TIME RATIO BY ADDING A PHENOLIC CATALYST TO POLYASPARTIC FLOORING FORMULATIONS COVESTRO LLC 2021-02-04 US claimed
EP-2567675-B1 BONE-TRANSPLANT OR BONE-FILLING COMPOSITION COMPRISING A DIHYDROXYBENZOIC ACID DERIVATIVE CELLSAFE CO LTD (KR) 2019-05-22 EP claimed
US-8871749-B2 Bone-transplant or bone-filling composition comprising a dihydroxybenzoic acid derivative CELLSAFE CO., LTD. (KR) 2014-10-28 US claimed
EP-2567675-A2 BONE-TRANSPLANT OR BONE-FILLING COMPOSITION COMPRISING A DIHYDROXYBENZOIC ACID DERIVATIVE Cellsafe Co. Ltd. (KR) 2013-03-13 EP claimed
US-20130053354-A1 BONE-TRANSPLANT OR BONE-FILLING COMPOSITION COMPRISING A DIHYDROXYBENZOIC ACID DERIVATIVE CELLSAFE CO., LTD. (KR) 2013-02-28 US claimed
CN-102065689-A RHO-kinase inhibitor compounds INSPIRE PHARMACEUTICALS INC 2011-05-18 CN claimed
US-20100168279-A1 THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS HENKEL AG & CO. KGAA (DE) 2010-07-01 US claimed
EP-2001924-A1 THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS National Starch and Chemical Investment Holding Corporation (US) 2008-12-17 EP claimed
WO-2007114822-A1 THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) 2007-10-11 WO claimed
WO-2003075882-A2 METHOD OF DEPIGMENTING SKIN AND HAIRS GHISALBERTI CARLO (BR) 2003-09-18 WO claimed
US-6280923-B1 LIGHT-INSENSITIVE SILVER SALT OF AN ORGANIC CARBOXYLIC ACID; PHOTOSENSITIVE SILVER HALIDE; BINDER; ORGANIC REDUCING AGENT FOR SAID SUBSTANTIALLY LIGHT-INSENSITIVE SILVER SALT AGFA-GEVAERT (BE) 2001-08-28 US claimed
US-12534670-B2 Liquid crystal compounds Rolic Technologies AG (CH) 2026-01-27 US disclosed
US-20250257167-A1 EXTENDED WORK TIME POLYASPARTIC FLOOR COATING FORMULATIONS COVESTRO LLC 2025-08-14 US disclosed
EP-0004684-A2 Stabilized radiographic scanning agents and method for preparing them THE PROCTER & GAMBLE COMPANY (US) 1979-10-17 EP disclosed
US-3933507-A LIGHT INSENSITIVE SILVER SALT, POLYMETHINE SENSITIZER AGFA-GEVAERT, A.G. (DT) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053354-A1 BONE-TRANSPLANT OR BONE-FILLING COMPOSITION COMPRISING A DIHYDROXYBENZOIC ACID DERIVATIVE BMP2, BMP6, BMP4 CA12 4301/4885CA1 3031/4885CA2 3575/4885
US-12534670-B2 Liquid crystal compounds SCO2, LBR, C1R CA12 340/4885CA1 558/4885CA2 344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.